Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S Linblad, 1991, Incidence of venous thromboembolism verified by necropsy over 30 years, BMJ, 302, 709, 10.1136/bmj.302.6778.709 Sandler, 1989, Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?, J R Soc Med, 82, 203, 10.1177/014107688908200407 Alikhan, 2004, Fatal pulmonary embolism in hospitalised patients: a necropsy review, J Clin Pathol, 57, 1254, 10.1136/jcp.2003.013581 Prandoni, 1997, The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients, Haematologica, 82, 423 Pengo, 2004, Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, 350, 2257, 10.1056/NEJMoa032274 Clagett, 1992, Prevention of venous thromboembolism, Chest, 102, 391S, 10.1378/chest.102.4_Supplement.391S Otero, 2001, Use of venous thromboembolism prophylaxis for surgical patients: a multicentre analysis of practice in Spain, Eur J Surg, 167, 163, 10.1080/110241501750099258 Yu, 2007, Hospitals'compliance with prophylaxis guidelines for venous thromboembolism, Am J Health Syst Pharm, 64, 69, 10.2146/ajhp060115 Eikelboom, 2004, Thromoboprophylaxis practice patterns in two Western Australian teaching hospitals, Haematologica, 89, 586 Amin, 2007, Thromboprophylaxis rates in US medical centers: success or failure?, J Thromb Haemost, 5, 1610, 10.1111/j.1538-7836.2007.02650.x Tapson, 2007, Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registery on venous thromboembolism, Chest, 132, 936, 10.1378/chest.06-2993 2006 Kakkar, 1975, Prevention of fatal postoperative pulmonary embolism by low doses of heparin: an international multicentre trial, Lancet, 306, 45, 10.1016/S0140-6736(75)90494-8 Baglin, 2006, Guidelines on the use and monitoring of heparin, Br J Haematol, 133, 19, 10.1111/j.1365-2141.2005.05953.x Nicolaides, 2006, Prevention and treatment of venous thromboembolism international consensus statement (guidelines according to scientific evidence), Int Angiol, 25, 101 Cohen, 2005, Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients, Thromb Haemost, 94, 750, 10.1160/TH05-06-0385 Kahn, 2007, Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada, Thromb Res, 119, 145, 10.1016/j.thromres.2006.01.011 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Cohen, 2006, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, 332, 325, 10.1136/bmj.38733.466748.7C Anderson, 2007, Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism, Am J Hematol, 82, 777, 10.1002/ajh.20983 Cohen, 2007, Venous thromboembolism in Europe: the number of VTE events and associated morbidity and mortality, Thromb Haemost, 98, 756, 10.1160/TH07-03-0212